Reduction of exacerbations by the PDE4 inhibitor roflumilast - the importance of defining different subsets of patients with COPD by Goehring Udo M, Calverley Peter MA, Rennard Stephen I, Bredenbröker Dirk, Martinez Fernando J

Get full text

One-year treatment with mometasone furoate in chronic obstructive pulmonary disease by Abbate Eduardo H, Karpel Jill P, Nelson Harold S, Rennard Stephen, Calverley Peter MA, Stryszak Paul, Staudinger Heribert

Get full text

Health status in the TORCH study of COPD: treatment efficacy and other determinants of change by Yates Julie C, Jenkins Christine, Ferguson Gary T, Celli Bartolome R, Calverley Peter MA, Anderson Julie A, Jones Paul W, Vestbo Jørgen, Spencer Michael D

Get full text

Characterisation of COPD heterogeneity in the ECLIPSE cohort by Agusti Alvar, Calverley Peter MA, Celli Bartolome, Coxson Harvey O, Edwards Lisa D, Lomas David A, MacNee William, Miller Bruce E, Rennard Steve, Silverman Edwin K, Tal-Singer Ruth, Wouters Emiel, Yates Julie C, Vestbo Jørgen

Get full text